Synaffix Licenses Metal-Free Click Chemistry Technology to Illumina for Next-Generation DNA Sequencing Applications
Agreement grants access to Synaffix patent portfolio related to metal-free click chemistry Technology to be used in Illumina’s next-generation sequencing (NGS) products AMSTERDAM, Dec. 4, 2024 /PRNewswire/ — Synaffix B.V., a Lonza company (SIX:LONN) focused on commercializing its clinica
ZINZINO AB (PUBL.): PRELIMINARY SALES REPORT NOVEMBER 2024
GOTHENBURG, Sweden, Dec. 4, 2024 /PRNewswire/ — Zinzino group revenue increased with a total of 26 %, compared with the previous year. The revenue in November for Zinzino’s sales markets increased by 26 % and amounted to SEK 252.7 (201.1) million. Faun Pharma’s external sales inc
Dream Vacations Travel Agency Franchise Enhances Its Comprehensive AI Suite
Suite of innovative AI tools empower travel agency franchise owners to streamline workflows and boost efficiency FORT LAUDERDALE, Fla., Dec. 4, 2024 /PRNewswire/ — At the Dream Vacations National Conference aboard Celebrity Ascent, the franchisor announced its latest AI-driven tools designed
LIAN Group strengthens its position in aesthetic medicine with the launch of Vitaura
GENEVA, Dec. 4, 2024 /PRNewswire/ — LIAN Group, investor and operator, announces the launch of Vitaura, a consolidation business in the aesthetic medicine, surgery, and longevity sector. With a similar format as the former Cheeze Dentistry Network, the objective is to create a network of exce
PhysicsX introduces free-to-use ‘AI for advanced engineering’ to transform aerospace development
PhysicsX releases the first Large Geometry Model, LGM-Aero, for aerospace engineering, trained and provisioned on Amazon Web Services (AWS) cloud compute using more than 25 million different shapes. It reduces the time to investigate aerospace concepts from months to hours. Trained and provisioned o
Antag Therapeutics Announces €80 Million Series A Financing
— Round led by Versant Ventures with participation from founding investor Novo Holdings and new investors SR One, Dawn Biopharma and Pictet– –Entering Phase I testing for next-generation weight loss therapy by antagonizing GIPR– COPENHAGEN, Denmark, Dec. 4, 2024 /PRNewswire
A Glimpse into the Future with KuCoin at VTIS 2024
HANOI, Vietnam, Dec. 4, 2024 /PRNewswire/ — KuCoin, a leading global exchange, has proudly hosted an enlightening substage session at the prestigious VTIS event on December 3rd, drawing a crowd of over 300 participants to Stage C with 4 insightful panels and 2 inspiring speeches. The session,
High-net-worth Investors Are Embracing Tech To Grow Their Wealth: Moomoo Singapore Survey
These investors are more confident in utilising wealth-tech to make their investment decisions As gatekeepers for their clients’ wealth, wealth managers must evolve to meet the needs of an increasingly sophisticated investor SINGAPORE, Dec. 4, 2024 /PRNewswire/ — High-net-worth investors
The Millionth Export of Chery TIGGO 7 Marks Milestone in Global Expansion Strategy
WUHU, China, Dec. 4, 2024 /PRNewswire/ — On November 1st, 2024, the TIGGO product line reached a major milestone as the millionth Chery TIGGO 7 began its journey to the global market from Wuhu Port in China. Since its inception, this model has earned global acclaim for its superior performance
Hexagon AB’s Nomination Committee proposes the election of Mr. Björn Rosengren as new Vice Chairman of the Hexagon Board of Directors
STOCKHOLM, Dec. 4, 2024 /PRNewswire/ — Hexagon AB’s nomination committee proposes the election of Mr. Björn Rosengren as new Vice Chairman of the Hexagon Board of Directors at the Annual General Meeting (AGM) on 5 May 2025. Björn Rosengren stepped down as CEO of ABB Ltd. in July and b
